FIELD: medicine.
SUBSTANCE: invention concerns technology of genetically engineered constructs to be applied in cell-based and gene therapy. Gene of human hepatocyte growth factor optimised for expression in mammal cells is presented.
EFFECT: invention allows doubling the production of hepatocyte growth factor in comparison with a human natural gene.
3 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
| AGPopt GENE OF ANGIOPOIETIN-1 | 2008 |
|
RU2385938C1 |
| VEGFopt GENE OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR | 2008 |
|
RU2385937C1 |
| METALLOPROTEINASE-8 MMP8opt GENE | 2008 |
|
RU2378376C1 |
| METALLOPROTEINASE-1 MMP1opt GENE | 2008 |
|
RU2378377C1 |
| MEDICINAL AGENT FOR TREATING HEPATIC FIBROSIS, METHOD FOR PRODUCTION THEREOF AND METHOD OF TREATING HEPATIC FIBROSIS | 2015 |
|
RU2615445C2 |
| AGENT PROMOTING THERAPEUTIC ANGIOGENESIS AND METHOD FOR IMPLEMENTATION THEREOF | 2009 |
|
RU2449799C2 |
| INTEGRATIVE PLASMID VECTOR FOR EXPRESSION OF GENES IN YEAST | 2008 |
|
RU2388823C1 |
| METHOD OF PRODUCING DIMERIC FORM OF MUTANT IGA2M1-ISOTYPE IMMUNOGLOBULIN IN MAMMALIAN CELLS | 2023 |
|
RU2822889C1 |
| METHOD OF PRODUCING DIMERIC FORM OF IMMUNOGLOBULIN IGA1-ISOTYPE IN MAMMALIAN CELLS | 2023 |
|
RU2822890C1 |
